HomePCVX • NASDAQ
add
Vaxcyte Inc
Previous close
$50.24
Day range
$48.91 - $50.12
Year range
$27.66 - $94.76
Market cap
6.37B USD
Avg Volume
1.45M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 242.38M | 73.22% |
Net income | -212.83M | -106.38% |
Net profit margin | — | — |
Earnings per share | -1.56 | -87.12% |
EBITDA | -239.32M | -73.25% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.71B | -21.52% |
Total assets | 3.17B | -10.90% |
Total liabilities | 278.72M | 96.13% |
Total equity | 2.89B | — |
Shares outstanding | 130.91M | — |
Price to book | 2.26 | — |
Return on assets | -18.71% | — |
Return on capital | -19.76% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -212.83M | -106.38% |
Cash from operations | -143.30M | -136.06% |
Cash from investing | 121.17M | 113.21% |
Cash from financing | -3.67M | -100.24% |
Net change in cash | -25.52M | -104.80% |
Free cash flow | -78.44M | -19.22% |
About
Founded
2013
Headquarters
Website
Employees
414
